MISSISSAUGA, ON, March 11,
2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH)
(OTCQX: CPHRF) ("Cipher" or the "Company") today
announced that it will release its financial results for the fourth
quarter and fiscal 2024 after the market close on Tuesday, March 18, 2025. The Company will also
hold a conference call on Wednesday, March
19, 2025 at 8:30am ET to
discuss the results and corporate developments.
CONFERENCE CALL DETAILS
|
DATE:
|
Wednesday, March 19,
2025
|
|
TIME:
|
8:30 a.m. ET
|
|
DIAL-IN
NUMBER:
|
416-945-7677 or
888-699-1199
|
|
REPLAY:
|
289-819-1450 or
888-660-6345 Code: 49540#
|
|
Expires: March 26,
2025
|
|
WEBCAST:
|
https://app.webinar.net/A3drRqWpovk
|
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty
pharmaceutical company with a robust and diversified portfolio of
commercial and early to late-stage products, mainly in dermatology.
Cipher acquires products that fulfill unmet medical needs, manages
the required clinical development and regulatory approval process,
and currently markets those products in Canada, the U.S.,
and South America. For more information,
visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
